Induction of SARS-CoV-2 neutralizing antibodies by CoronaVac and BNT162b2 vaccines in naïve and previously infected individuals-Reference-Cited by-同舟云学术

Induction of SARS-CoV-2 neutralizing antibodies by CoronaVac and BNT162b2 vaccines in naïve and previously infected individuals

Published:2022-04 Issue: Volume:78 Page:103972
ISSN:2352-3964
Container-title:eBioMedicine
language:en
Short-container-title:eBioMedicine

Author:

Muena Nicolás A.,García-Salum Tamara,Pardo-Roa Catalina,Avendaño María José,Serrano Eileen F.,Levican Jorge,Almonacid Leonardo I.,Valenzuela Gonzalo,Poblete Estefany,Strohmeier Shirin,Salinas Erick,Muñoz Andres,Haslwanter Denise^ORCID,Dieterle Maria Eugenia,Jangra Rohit K.,Chandran Kartik,González Claudia,Riquelme Arnoldo^ORCID,Krammer Florian,Tischler Nicole D.,Medina Rafael A.^ORCID

Publisher

Elsevier BV

Subject

General Biochemistry, Genetics and Molecular Biology,General Medicine

Reference49 articles.

1. Antibody response to SARS-CoV-2 infection in humans: a systematic review;Post;PLoS ONE,2020

2. Robust neutralizing antibodies to SARS-CoV-2 infection persist for months;Wajnberg;Science,2020

3. Immunological memory to SARS-CoV-2 assessed for up to 8 months after infection;Dan;Science,2021

4. Evolution of antibody immunity to SARS-CoV-2;Gaebler;Nature,2021

5. Longitudinal analysis of humoral immunity against SARS-CoV-2 Spike in convalescent individuals up to 8 months post-symptom onset;Anand;Cell Rep Med,2021

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Quantitative microfluidic assay to measure neutralizing and total antibodies for SARS-CoV-2;Sensors and Actuators B: Chemical;2024-03

2. Diverse immune responses in vaccinated individuals with and without symptoms after omicron exposure during the recent outbreak in Guangzhou, China;Heliyon;2024-01

3. BNT162b2 Booster Dose Elicits a Robust Antibody Response in Subjects with Abdominal Obesity and Previous SARS-CoV-2 Infection;Vaccines;2023-11-30

4. Development of a novel medium throughput flow-cytometry based micro-neutralisation test for SARS-CoV-2 with applications in clinical vaccine trials and antibody screening;PLOS ONE;2023-11-30

5. Improving SARS-CoV-2 variants monitoring in the absence of genomic surveillance capabilities: a serological study in Bolivian blood donors in October 2021 and June 2022;2023-11-23